These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5941697)

  • 1. Preliminary experiments on the effect of Persantin on the animal heart.
    Keegan DJ; Webster I
    S Afr Med J; 1966 May; 40(19):429-33. PubMed ID: 5941697
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of Persantin and nitroglycerin on systemic and coronary hemodynamics in the dog. Preliminary note].
    Pandolfo G; Uslenghi E; Dessy P; Gagna C; Brocchi G; Giannini R; Campus S
    Minerva Cardioangiol; 1970 Oct; 18(10):589-93. PubMed ID: 4993306
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of dipyridamole on coronary post-occlusion hyperaemia and on myocardial vasodilatation induced by systemic hypoxia.
    Parratt JR; Wadsworth RM
    Br J Pharmacol; 1972 Dec; 46(4):594-601. PubMed ID: 4655264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the effect of peruvoside on heart function in animal experiments].
    Schorscher E; Sommer S; Wild AJ; Block A
    Arzneimittelforschung; 1968 Dec; 18(12):1582-90. PubMed ID: 5756257
    [No Abstract]   [Full Text] [Related]  

  • 5. [The influence of long term dipyridamole application on the coronary flow and isoproterenol and papaverine effects on the isolated hearts of small mammals].
    Mentz P; Förster W; Wartner U
    Arch Int Pharmacodyn Ther; 1973 Dec; 206(2):317-24. PubMed ID: 4778622
    [No Abstract]   [Full Text] [Related]  

  • 6. [Coronary circulation. 2. Coronary resistance, (3) propranolol (Indersal), (4) dipyridamole (Persantin) and vasopressin (Pitressin)].
    Saito T
    Masui; 1972 May; 21(5):479-86. PubMed ID: 4561562
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypoxia and the heart ultrastructure with special reference to the protective action of the coronary drug Persantin.
    Lozada BB; Laguens RP
    Cardiologia (Basel); 1966; 49():Suppl 1:33-43. PubMed ID: 5989065
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the effect of overdosage of persantin and low atmospheric pressure on myocardial ultrastructures in the rat].
    Poche R; Hausamen TU
    Virchows Arch Pathol Anat Physiol Klin Med; 1965 Jun; 339(3):234-44. PubMed ID: 5294333
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes of the coronary arteriovenous O2 difference in the man following intravenous injection of dipyridamol (Persantin)].
    Hilger HH; Wagner J; Hellwig H; Louven B; Wackerbauer J; Schaede A
    Z Kreislaufforsch; 1967 Dec; 56(12):1192-206. PubMed ID: 5593119
    [No Abstract]   [Full Text] [Related]  

  • 10. Potentiation of adenosine by dipyridamole.
    Stafford A
    Nature; 1967 Apr; 214(5086):390-1. PubMed ID: 6032839
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oxygen pressure and oxygen consumption in coronary venous blood as well as the changes of the arterio-coronary venous O2 content difference and the coronary circulation with high doses of 2,6-(diethanolamino)-4,-8-dipiperidinopyrimido -(5,4-d) pyrimidine (Persantin)].
    Doll E; Keul J; Brechtel
    Z Kreislaufforsch; 1966 Nov; 55(10):1076-97. PubMed ID: 5998956
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ultramicroscopic findings of the mechanism of action of novocamide on guinea pig hearts].
    Breitfellner G; Lungimayr G; Neuhold R
    Wien Klin Wochenschr; 1966 Nov; 78(47):831-3. PubMed ID: 5994700
    [No Abstract]   [Full Text] [Related]  

  • 13. [Animal experiment study on the coronary and circulatory effect of dipyridamole, carbocromen, hexobendine, dilazep and glucagon].
    Reploh HD
    Arzneimittelforschung; 1973 May; 23(5):629-39. PubMed ID: 4740201
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronary vasodilator properties of ethyl adenosine 5-carboxylate hydrochloride (Abbott-40557).
    Somani P
    Recent Adv Stud Cardiac Struct Metab; 1975; 7():413-20. PubMed ID: 1226452
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of dipyridamol on myocardial cells under hypoxia].
    Chévez A; Restelli M; Bernaldo de Quirós E; Segura M
    Arch Inst Cardiol Mex; 1970; 40(3):315-28. PubMed ID: 5477191
    [No Abstract]   [Full Text] [Related]  

  • 16. [BAY a 1040--a highly potent Ca ++ -antagonistic inhibitor of electro-mechanical coupling processes in mammalian myocardium].
    Fleckenstein A; Tritthart H; Döring HJ; Byon KY
    Arzneimittelforschung; 1972 Jan; 22(1):22-33. PubMed ID: 4259147
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of oxygen and Persantin (dipyridamole) on coronary circulation].
    Saito T; Hirano T
    Masui; 1972 Feb; 21(2):120-4. PubMed ID: 5063552
    [No Abstract]   [Full Text] [Related]  

  • 18. [Morphologic changes in the heart after administration of Persantin].
    López-Campos JL; Villa García M
    Rev Clin Esp; 1965 May; 97(3):184-90. PubMed ID: 5861764
    [No Abstract]   [Full Text] [Related]  

  • 19. [THE EFFECT OF PERORAL LONG-TERM TREATMENT WITH PERSANTIN IN DOGS ON CORONARY BLOOD FLOW DURING REST, AFTER NORADRENALIN AND ON THE SURVIVAL TIME OF THE HEART FOLLOWING TOTAL AORTA LIGATION].
    NEUHAUS G; NASSERI M; FIEDLER E; SEKI I
    Z Gesamte Exp Med; 1963 Dec; 137():574-86. PubMed ID: 14124498
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action of Persantin on the coronary circulation].
    Brugger A; Lluch S; Marco V; Esplugues J
    Rev Clin Esp; 1965 Sep; 98(6):401-4. PubMed ID: 5865268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.